Boehringer Kore, Yuhan to co-market Twinsta

Published: 2010-11-03 06:59:00
Updated: 2010-11-03 06:59:00
Boehringer Ingelheim Korea and Yuhan Corp. will jointly promote Twinsta, a combination drug of telmisartan and amlodipine, from November 1 here.

Twinsta is effective and well tolerated in a range of more complex, difficult-to-treat patients as well as in those whose blood pressure (BP) was pre...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.